{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 109,
        "end": 114
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 180,
        "end": 188
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 191,
        "end": 221
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 224,
        "end": 228
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 251,
        "end": 261
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 277,
        "end": 283
      }
    },
    {
      "id": "T11",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 288,
        "end": 294
      }
    },
    {
      "id": "T12",
      "obj": "Chemical",
      "span": {
        "begin": 345,
        "end": 353
      }
    },
    {
      "id": "T16",
      "obj": "Chemical",
      "span": {
        "begin": 331,
        "end": 344
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "20487194_4",
  "text": "Successful results that have been achieved within the field of pharmacogenomics so far are , to name a few , HLA-B * 5701 screening to avoid hypersensitivity to the antiretroviral abacavir , thiopurine S-methyltransferase ( TPMT ) genotyping to avoid thiopurine toxicity , and CYP2C9 and VKORC1 genotyping for better dosing of the anticoagulant warfarin ."
}
